Mannan-binding protein, a c-type serum lectin, recognizes primary colorectal carcinomas through tumor-Associated lewis glycans

Journal of Immunology

Volumn 192, Issue 3, 2014, Pages 1294-1301

  Nonaka, Motohiro ^a,b   Imaeda, Hirotsugu ^c   Matsumoto, Shogo ^a   Ma, Bruce Yong ^a,d,e,f   Kawasaki, Nobuko ^a   Mekata, Eiji ^c   Andoh, Akira ^g   Saito, Yasuharu ^c   Tani, Tohru ^c   Fujiyama, Yoshihide ^c   Kawasaki, Toshisuke ^a  

^a RITSUMEIKAN UNIVERSITY   (Japan)

^b BURNHAM INSTITUTE   (United States)

^c SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^d CHANGZHOU UNIVERSITY   (China)

^e ZonHon Biopharma Institute   (China)

^f MURORAN INSTITUTE OF TECHNOLOGY   (Japan)

^g SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CA 19-9 ANTIGEN; CALCIUM ION; FUCOSE; GLYCAN DERIVATIVE; MANNAN BINDING LECTIN; MANNOSE; PLANT LECTIN; TUMOR ASSOCIATED LEWIS GLYCAN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BINDING AFFINITY; CANCER CELL; CANCER DIAGNOSIS; CANCER PROGNOSIS; CELL DIFFERENTIATION; COLORECTAL CARCINOMA; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FLUORESCENCE HISTOCHEMISTRY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION;

ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; CA-19-9 ANTIGEN; COLORECTAL NEOPLASMS; EPITHELIUM; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HLA-DR ANTIGENS; HUMANS; INTESTINAL MUCOSA; LIGANDS; LYMPHOCYTES, TUMOR-INFILTRATING; MANNOSE-BINDING LECTIN; MIDDLE AGED; NEOPLASM METASTASIS; OLIGOSACCHARIDES; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS;

EID: 84893345726     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1203023     Document Type: Article

References (40)

1. Kawasaki, N., T. Kawasaki, and I. Yamashina. 1983. Isolation and characterization of a mannan-binding protein from human serum. J. Biochem. 94: 937-947.
2. Kawasaki, T. 1999. Structure and biology of mannan-binding protein, MBP, an important component of innate immunity. Biochim. Biophys. Acta 1473: 186-195.
3. Takahashi, K., W. E. Ip, I. C. Michelow, and R. A. Ezekowitz. 2006. The mannose-binding lectin: a prototypic pattern recognition molecule. Curr. Opin. Immunol. 18: 16-23.
4. Dommett, R. M., N. Klein, and M. W. Turner. 2006. Mannose-binding lectin in innate immunity: past, present and future. Tissue Antigens 68: 193-209.
5. Kawasaki, N., T. Kawasaki, and I. Yamashina. 1989. A serum lectin (mannanbinding protein) has complement-dependent bactericidal activity. J. Biochem. 106: 483-489.
6. Super, M., S. Thiel, J. Lu, R. J. Levinsky, and M. W. Turner. 1989. Association of low levels of mannan-binding protein with a common defect of opsonisation. Lancet 2: 1236-1239.
7. Hoffmann, J. A., F. C. Kafatos, C. A. Janeway, and R. A. Ezekowitz. 1999. Phylogenetic perspectives in innate immunity. Science 284: 1313-1318.
8. Ikeda, K., T. Sannoh, N. Kawasaki, T. Kawasaki, and I. Yamashina. 1987. Serum lectin with known structure activates complement through the classical pathway. J. Biol. Chem. 262: 7451-7454.
9. Malhotra, R., J. Lu, U. Holmskov, and R. B. Sim. 1994. Collectins, collectin receptors and the lectin pathway of complement activation. Clin. Exp. Immunol. 97(Suppl. 2): 4-9.
10. Mizuno, Y., Y. Kozutsumi, T. Kawasaki, and I. Yamashina. 1981. Isolation and characterization of a mannan-binding protein from rat liver. J. Biol. Chem. 256: 4247-4252.
11. Weis, W. I., K. Drickamer, and W. A. Hendrickson. 1992. Structure of a C-type mannose-binding protein complexed with an oligosaccharide. Nature 360: 127-134.
12. Weis, W. I., and K. Drickamer. 1994. Trimeric structure of a C-type mannosebinding protein. Structure 2: 1227-1240.
13. Lee, R. T., Y. Ichikawa, M. Fay, K. Drickamer, M. C. Shao, and Y. C. Lee. 1991. Ligand-binding characteristics of rat serum-type mannose-binding protein (MBP-A). Homology of binding site architecture with mammalian and chicken hepatic lectins. J. Biol. Chem. 266: 4810-4815.
14. Ma, Y., K. Uemura, S. Oka, Y. Kozutsumi, N. Kawasaki, and T. Kawasaki. 1999. Antitumor activity of mannan-binding protein in vivo as revealed by a virus expression system: mannan-binding protein dependent cell-mediated cytotoxicity. Proc. Natl. Acad. Sci. USA 96: 371-375.
15. Terada, M., K. H. Khoo, R. Inoue, C. I. Chen, K. Yamada, H. Sakaguchi, N. Kadowaki, B. Y. Ma, S. Oka, T. Kawasaki, and N. Kawasaki. 2005. Characterization of oligosaccharide ligands expressed on SW1116 cells recognized by mannan-binding protein. A highly fucosylated polylactosamine type N-glycan. J. Biol. Chem. 280: 10897-10913.
16. Nakamura, N., M. Nonaka, B. Y. Ma, S. Matsumoto, N. Kawasaki, S. Asano, and T. Kawasaki. 2009. Characterization of the interaction between serum mannanbinding protein and nucleic acid ligands. J. Leukoc. Biol. 86: 737-748.
17. Fukui, S., T. Horie, Y. Numata, H. Kitagawa, H. Nakada, T. Kawasaki, I. Funakoshi, and I. Yamashina. 1991. Characterization of mucin antigens recognized by monoclonal antibodies raised against human colon cancer cells. Cancer Res. 51: 331-335.
18. Kanda, Y. 2013. Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant. 48: 452-458.
19. Sun, J., J. Thurin, H. S. Cooper, P. Wang, M. Mackiewicz, Z. Steplewski, and M. Blaszczyk-Thurin. 1995. Elevated expression of H type GDP-L-fucose:beta-D-galactoside alpha-2-L-fucosyltransferase is associated with human colon adenocarcinoma progression. Proc. Natl. Acad. Sci. USA 92: 5724-5728.
20. Iwakawa, K., N. Ueda, S. Murao, and N. Kobayashi. 1996. Altered carbohydrate composition in colorectal adenomas and carcinomas: histochemical characterization of N-Acetylgalactosamine, L-fucose, and o-Acetylated sialic acid. J. Gastroenterol. 31: 24-32.
21. Fernández-Rodríguez, J., M. Páez de la Cadena, V. S. Martínez-Zorzano, and F. J. Rodríguez-Berrocal. 1997. Fucose levels in sera and in tumours of colorectal adenocarcinoma patients. Cancer Lett. 121: 147-153.
22. Fukui, S., T. Feizi, C. Galustian, A. M. Lawson, and W. Chai. 2002. Oligosaccharide microarrays for high-throughput detection and specificity assignments of carbohydrate-protein interactions. Nat. Biotechnol. 20: 1011-1017.
23. Ito, H., K. Tashiro, M. R. Stroud, T. F. Orntoft, P. Meldgaard, A. K. Singhal, and S. Hakomori. 1992. Specificity and immunobiological properties of monoclonal antibody IMH2, established after immunization with Le(b)/Le(a) glycosphingolipid, a novel extended type 1 chain antigen. Cancer Res. 52: 3739-3745.
24. Hakomori, S. 1991. Possible functions of tumor-Associated carbohydrate antigens. Curr. Opin. Immunol. 3: 646-653.
25. Watanabe, M., T. Ohishi, M. Kuzuoka, E. D. Nudelman, M. R. Stroud, T. Kubota, S. Kodairo, O. Abe, S. Hirohashi, Y. Shimosato, et al. 1991. In vitro and in vivo antitumor effects of murine monoclonal antibody NCCST-421 reacting with dimeric Le(a) (Le(a)/Le(a)) epitope. Cancer Res. 51: 2199-2204.
26. Kawasaki, N., C. W. Lin, R. Inoue, K. H. Khoo, N. Kawasaki, B. Y. Ma, S. Oka, M. Ishiguro, T. Sawada, H. Ishida, et al. 2009. Highly fucosylated N-glycan ligands for mannan-binding protein expressed specifically on CD26 (DPPVI) isolated from a human colorectal carcinoma cell line, SW1116. Glycobiology 19: 437-450.
27. Kawasaki, N., and T. Kawasaki. 2010. Recognition of endogenous ligands by Ctype lectins:interaction of serum mannan-binding protein with tumor-Associated oligosaccharide epitopes. Trends Glycosci. Glycotechnol. 22: 141-151.
28. de Bruin, E. C., C. J. van de Velde, J. H. van Krieken, C. A. Marijnen, and J. P. Medema. 2008. Epithelial human leukocyte antigen-DR expression predicts reduced recurrence rates and prolonged survival in rectal cancer patients. Clin. Cancer Res. 14: 1073-1079.
29. Matsushita, K., T. Takenouchi, S. Kobayashi, H. Hayashi, K. Okuyama, T. Ochiai, A. Mikata, and K. Isono. 1996. HLA-DR antigen expression in colorectal carcinomas: influence of expression by IFN-gamma in situ and its association with tumour progression. Br. J. Cancer 73: 644-648.
30. Matsushita, K., T. Takenouchi, H. Shimada, T. Tomonaga, H. Hayashi, A. Shioya, A. Komatsu, H. Matsubara, and T. Ochiai. 2006. Strong HLA-DR antigen expression on cancer cells relates to better prognosis of colorectal cancer patients: Possible involvement of c-myc suppression by interferon-gamma in situ. Cancer Sci. 97: 57-63.
31. Dahlin, A. M., M. L. Henriksson, B. Van Guelpen, R. Stenling, A. Oberg, J. Rutegard, and R. Palmqvist. 2011. Colorectal cancer prognosis depends on T-cell infiltration and molecular characteristics of the tumor. Mod. Pathol. 24: 671-682.
32. Rudd, P. M., T. Elliott, P. Cresswell, I. A. Wilson, and R. A. Dwek. 2001. Glycosylation and the immune system. Science 291: 2370-2376.
33. Dahiya, R., S. H. Itzkowitz, J. C. Byrd, and Y. S. Kim. 1989. ABH blood group antigen expression, synthesis, and degradation in human colonic adenocarcinoma cell lines. Cancer Res. 49: 4550-4556.
34. Itzkowitz, S. H., M. Yuan, L. D. Ferrell, A. Palekar, and Y. S. Kim. 1986. Cancer-Associated alterations of blood group antigen expression in human colorectal polyps. Cancer Res. 46: 5976-5984.
35. Kim, Y. S., M. Yuan, S. H. Itzkowitz, Q. B. Sun, T. Kaizu, A. Palekar, B. F. Trump, and S. Hakomori. 1986. Expression of LeY and extended LeY blood group-related antigens in human malignant, premalignant, and nonmalignant colonic tissues. Cancer Res. 46: 5985-5992.
36. Itzkowitz, S. H., M. Yuan, Y. Fukushi, H. Lee, Z. R. Shi, V. Zurawski, Jr., S. Hakomori, and Y. S. Kim. 1988. Immunohistochemical comparison of Lea, monosialosyl Lea (CA 19-9), and disialosyl Lea antigens in human colorectal and pancreatic tissues. Cancer Res. 48: 3834-3842.
37. Kim, Y. S., and S. H. Itzkowitz. 1988. Carbohydrate antigen expression in the adenoma-carcinoma sequence. Prog. Clin. Biol. Res. 279: 241-250.
38. Itzkowitz, S. H., R. Dahiya, J. C. Byrd, and Y. S. Kim. 1990. Blood group antigen synthesis and degradation in normal and cancerous colonic tissues. Gastroenterology 99: 431-442.
39. Herlyn, M., H. F. Sears, Z. Steplewski, and H. Koprowski. 1982. Monoclonal antibody detection of a circulating tumor-Associated antigen. I. Presence of antigen in sera of patients with colorectal, gastric, and pancreatic carcinoma. J. Clin. Immunol. 2: 135-140.
40. Kouri, M., S. Pyrhonen, and P. Kuusela. 1992. Elevated CA19-9 as the most significant prognostic factor in advanced colorectal carcinoma. J. Surg. Oncol. 49: 78-85.